Welcome to our dedicated page for AVISTA SEC filings (Ticker: AVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AVISTA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AVISTA's regulatory disclosures and financial reporting.
Joshua D. DiLuciano, Vice President and director of Avista Corp (AVA), reported an annual Form 5 disclosing a small non-derivative acquisition and his year-end holdings. On 03/14/2025 he acquired 26.0699 shares of Avista common stock at a reported price of $40.1475 related to an inadvertent reinvestment of dividends. At the end of the issuer's fiscal year he beneficially owned 12,872.0699 shares, held directly. The filing is signed and dated 09/17/2025.
David J. Meyer, a vice president and director at Avista Corp (AVA), filed a Form 5 reporting small, inadvertent dividend reinvestment purchases during the 2025 fiscal year. On 03/14/2025 he acquired 27.5467 shares at $40.1475 and on 06/13/2025 he acquired 11.4385 shares at $37.5066, a combined 38.9852 shares added via reinvestment. At year-end he beneficially owned 8,432.9851 shares directly. He also reported indirect holdings of 6.62 shares in the 401(k) plan and 3,688.86 shares in an executive deferral plan; a trustee-held position is listed without a disclosed amount. The filing is signed and dated 09/17/2025 and notes both transactions were "inadvertent reinvestment of Dividends."
Avista Corporation (AVA) insider sale reported on Form 4. David J. Meyer, Vice President and director, sold 1,367 shares of Avista common stock on 09/05/2025 at a price of $36.72 per share. After the transaction the filing shows 8,394 shares beneficially owned directly. The filing also discloses indirect holdings in a 401(k) and executive deferral arrangements.
Avista Corporation (AVA) Form 144 shows a proposed sale of 1,367 shares of common stock through Georgeson Securities Corp with an aggregate market value of $50,045.87. The securities were acquired as restricted stock vesting from Avista Corporation on 09/05/2025 and payment is shown as services rendered. The filer lists the approximate date of sale as 09/05/2025 on the NYSE and reports 81,110,750 shares outstanding. The form states there were no securities sold in the past three months by the account and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Avista Corporation (AVA) director Janet D. Widmann received 91 shares of common stock as director compensation on 09/02/2025. The shares were issued as an award for director compensation and as part of the director's annual retainer. The per-share price used for reporting was $36.54, which is the closing price on August 29, 2025. After the transaction, Ms. Widmann beneficially owned 26,646 shares in total.
This Form 4 reports a routine, non-derivative grant to a director and is filed by one reporting person. The form is signed and dated 09/04/2025.
Avista Corporation director Heidi B. Stanley received 91 shares of Avista common stock as director compensation on 09/02/2025 at a unit price of $36.54, reflecting the closing price on August 29, 2025. After the award, Ms. Stanley beneficially owns 27,745 shares directly. Separately, 9,248 shares are held indirectly in a company profit sharing plan and are reported as shares held by a trustee. The Form 4 was signed by Ms. Stanley on 09/04/2025 and discloses the grant as part of the directors’ annual retainer.
Avista Corporation director Jeffry L. Philipps received 91 shares of Avista common stock as director compensation on 09/02/2025. The shares were issued as part of the director's annual retainer and are valued at $36.54 per share, which is the closing price used from August 29, 2025. After this issuance, Mr. Philipps beneficially owned 17,395 shares. The transaction was reported on a Form 4 filed by one reporting person and signed on 09/04/2025.
Scott L. Morris, a director and Chairman of the Board of Avista Corporation (AVA), received 91 shares of Avista common stock as a director compensation award executed on 09/02/2025. The grant used the closing price on August 29, 2025, of $36.54 per share to value the award. Following the transaction, Mr. Morris beneficially owned 115,671 shares of Avista common stock on a direct basis. The filing is reported on a Form 4 and indicates the shares were issued as part of the director annual retainer and as an award for director compensation.
Avista Corporation director Scott H. Maw received 91 shares as director compensation on 09/02/2025. The shares were issued as an award and as part of the director's annual retainer at a reported price of $36.54 per share, which the filer notes equals the closing price on August 29, 2025. After the issuance, the reporting person beneficially owns 29,847 shares. The Form 4 was signed on 09/04/2025 and filed to disclose this change in beneficial ownership.
Avista Corporation (AVA) Form 4: Director Sena M. Kwawu received 91 shares as a stock award for director compensation on 09/02/2025, priced at the closing share price of $36.54 on August 29, 2025. The transaction is reported as an acquisition resulting from the director annual retainer. Following the award, Mr. Kwawu is shown as beneficially owning 14,877.14 shares directly. The filing is a routine Section 16 disclosure documenting compensation-related equity granted to a director and is signed on 09/04/2025.